Schizophrenia: all 3,539 studies
Page 2 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Social Isolation and Aging in SchizophreniaRecruitingNCT07419321
- Emotional Eating, Sleep Quality, Mental State and Metabolic SyndromeRecruitingNCT07411222
- A Study of Brenipatide in Adult Participants With SchizophreniaRecruitingNCT07410507Phase 2
- A Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)Enrolling by invitationNCT07408934Not applicable
- Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant SchizophreniaNot yet recruitingNCT07404319Not applicable
- Epigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder PopulationsRecruitingNCT07404085Not applicable
- Medical Phenotyping of NHS General Adult Psychiatry (GAP) InpatientsRecruitingNCT07398365
- A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With SchizophreniaNot yet recruitingNCT07396870Phase 2
- Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum DisordersRecruitingNCT07395206Not applicable
- PQQ for Cognitive and Negative SymptomsNot yet recruitingNCT07393464Not applicable
- Heat Stress in Individuals With SchizophreniaRecruitingNCT07383324Not applicable
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)RecruitingNCT07379827
- Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS ProtocolRecruitingNCT07375199Not applicable
- 52-week Open Label Safety-Tolerability StudyRecruitingNCT07369154Phase 3
- Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaRecruitingNCT07363577Phase 3
- Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and MechanismsEnrolling by invitationNCT07356765Not applicable
- Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable SchizophreniaRecruitingNCT07344948Early Phase 1
- Gamma Light and Sound Stimulation in SchizophreniaNot yet recruitingNCT07342465Not applicable
- Relapse Management Group Psychoeducation ProgramNot yet recruitingNCT07327944Not applicable
- Group Intervention for Romantic Relationships in Young Adults With Severe Mental IllnessRecruitingNCT07316803Not applicable
- Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant AggressionNot yet recruitingNCT07315685Not applicable
- KetoBrain: Brain Energy Metabolism in SchizophreniaRecruitingNCT07309172
- Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life StudyNot yet recruitingNCT07309159Phase 1/2
- Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of LifeRecruitingNCT07306468
- Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric DisordersRecruitingNCT07295652Not applicable
- A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)RecruitingNCT07288567Phase 3
- Evaluation of NBI-1117570 in Inpatient Adults With SchizophreniaRecruitingNCT07288333Phase 2
- Effects of Transcranial Direct Current Stimulation on Cognitive Rehabilitation in SchizophreniaEnrolling by invitationNCT07273175Not applicable
- Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPSNot yet recruitingNCT07266376Not applicable
- Cognitive Strategies in Early Psychosis 2RecruitingNCT07263022Phase 3
- Dopamine and Insulin in PsychosisNot yet recruitingNCT07252752Not applicable
- PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and TraumasRecruitingNCT07242586Not applicable
- What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis?Not yet recruitingNCT07237529Not applicable
- Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.Enrolling by invitationNCT07234851
- Feeling Safe StudyRecruitingNCT07234708Not applicable
- A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020RecruitingNCT07230652Phase 1
- Efficacy of NBI-1117568 in Preventing Relapse in Adults With SchizophreniaRecruitingNCT07227818Phase 3
- A Long-term Administration Trial of SEP-363856 in Patients With SchizophreniaRecruitingNCT07225712Phase 3
- A Study to Evaluate the Effect of KarXT on Urological SafetyRecruitingNCT07221877Phase 4
- Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive FlexibilityRecruitingNCT07217652Not applicable
- Precision Brain Stimulation to Reduce Cannabis Craving in SchizophreniaRecruitingNCT07196462Not applicable
- Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With SchizophreniaRecruitingNCT07192042
- Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral CariprazineRecruitingNCT07185815Phase 1/2
- This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.Not yet recruitingNCT07184710
- Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant SchizophreniaRecruitingNCT07184619Phase 3
- Inter-Brain Synchrony in SchizophreniaRecruitingNCT07177261Not applicable
- Personalized iTBS in Real-World Clinical Settings for SchizophreniaRecruitingNCT07176468Not applicable
- The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia PatientsEnrolling by invitationNCT07173192Not applicable
- Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.Enrolling by invitationNCT07162467
- Online Intervention To Improve MotivationNot yet recruitingNCT07157293Not applicable
- AI-assisted Masticatory Muscle Training in Patients With SchizophreniaNot yet recruitingNCT07154407Not applicable
- Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh StudyNot yet recruitingNCT07153835Phase 4
- A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With SchizophreniaRecruitingNCT07145918Phase 2
- The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With SchizophreniaRecruitingNCT07144592Not applicable
- Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode SchizophreniaRecruitingNCT07139171
- A Remote Life Balance Training Program for People With SchizophreniaEnrolling by invitationNCT07131137Not applicable
- Incentives and Long-Acting Injectable Adherence After Involuntary HospitalizationEnrolling by invitationNCT07130500Not applicable
- Sex Differences in NMDA-enhancing Treatment of SchizophreniaRecruitingNCT07122895Phase 2
- Recovery With Exogenous Ketones and AntipsychoticsRecruitingNCT07122531Not applicable
- Tele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families (Definitive tgCBFI)RecruitingNCT07121166Not applicable
- SPARK Healthy SleepRecruitingNCT07119268Not applicable
- NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With SchizophreniaRecruitingNCT07114874Phase 3
- Value of Voxel-Based Morphometry in SchizophreniaNot yet recruitingNCT07108673
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorRecruitingNCT07105111Phase 4
- NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With SchizophreniaRecruitingNCT07105098Phase 3
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)RecruitingNCT07101094
- Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective AccuracyRecruitingNCT07098169Not applicable
- Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for PsychosisRecruitingNCT07091344Not applicable
- Effects of RAS in SZNot yet recruitingNCT07086040Not applicable
- Norwegian Mental Illness Heart Health StudyRecruitingNCT07085923Not applicable
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaNot yet recruitingNCT07084831Phase 3
- Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in SchizophreniaNot yet recruitingNCT07075237Phase 4
- A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXTRecruitingNCT07061288Phase 1
- Bilateral Prefrontal and Insular TMS for Depression in SchizophreniaRecruitingNCT07060066Not applicable
- Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.RecruitingNCT07058389Not applicable
- Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for SchizophreniaRecruitingNCT07055204Not applicable
- Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia PatientsRecruitingNCT07045142Phase 3
- A Clinical Trial of Adjunctive Thyroxine for Avolition in SchizophreniaNot yet recruitingNCT07011953Early Phase 1
- Brain Stimulation to the Hippocampus in SchizophreniaRecruitingNCT07010614Not applicable
- REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)RecruitingNCT07006935Not applicable
- Role of Inferior Colliculi in Auditory HallucinationsRecruitingNCT07003529Not applicable
- A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017Not yet recruitingNCT06980207Phase 1
- Magnetoencephalography in Psychosis ProgramEnrolling by invitationNCT06978881
- HYEEG Discourse in Psychosis: A Neurobehavioural StudyRecruitingNCT06978803
- DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in PsychosisNot yet recruitingNCT06978465
- ACT-Based Psychoeducation for Schizophrenia CaregiversNot yet recruitingNCT06971328Not applicable
- Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingNCT06969755Phase 4
- A Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health ConditionsNot yet recruitingNCT06964477Not applicable
- NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With SchizophreniaRecruitingNCT06963034Phase 3
- Randomized Withdrawal Study in Patients With SchizophreniaRecruitingNCT06961968Phase 3
- Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)RecruitingNCT06961916Not applicable
- Investigating the Effect of Diroximel Fumarate on Glutathione in SchizophreniaRecruitingNCT06957808Not applicable
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderRecruitingNCT06939088Phase 2
- Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional RegulationRecruitingNCT06936397Not applicable
- An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With SchizophreniaNot yet recruitingNCT06924255Phase 4
- An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia PatientsNot yet recruitingNCT06923891Phase 4
- Visual Perception in SchizophreniaRecruitingNCT06911931Not applicable
- Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy ControlsRecruitingNCT06911723Not applicable
- Mobile Thinking Intervention: A Inital TestNot yet recruitingNCT06909422Not applicable
- 40 Hz Visual Stimulation as an Intervention in SchizophreniaRecruitingNCT06907420Not applicable